Compartilhar
Informação da revista
Vol. 45. Núm. S4.
HEMO 2023
Páginas S378-S379 (Outubro 2023)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 45. Núm. S4.
HEMO 2023
Páginas S378-S379 (Outubro 2023)
Acesso de texto completo
PROGNOSTIC SIGNIFICANCE OF LMR AND RDW IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
Visitas
216
CA Assisa, LM Fogliattoa, L Damascenoa, MS Vieirab, LN Rottaa
a Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil
b Laboratório Zanol, Porto Alegre, Brazil
Este item recebeu
Informação do artigo
Suplemento especial
Este artigo faz parte de:
Vol. 45. Núm S4

HEMO 2023

Mais dados
Objective

The lymphocyte monocyte ratio (LMR) and red blood cell distribution width (RDW) are being recognized as useful prognostic tools for patients with Diffuse Large B Cell Lymphoma (DLBCL).

Methodology

We retrospectively analysed 98 data of DLBCL patients diagnosed between 2008 and 2018 from three hospitals in Porto Alegre/RS/Brazil and collected data form blood count cells and DHL.

Results

Patients with LMR ≤1.90 were in advanced stage of the disease (Ann Arbor stages III and IV p = 0.011), had a high LDH (p < 0.001) and age ≤60 years (p = 0.026). Patients with RDW ≥14.25 were in advanced stage of the disease (p = 0.023) with these being older (6 years, p = 0.049). RDW and LMR showed significant prognostic of overall survival (OS) in univariate (p = 0.003 and p = 0.006) and multivariate analyses (p = 0.0018 and p = 0.021), respectively.

Conclusion

RDW and LMR are important independent prognostic factors. An elevated RDW and a decreased LMR are associated with a bad/worst prognosis in newly diagnosed DLBCL. RDW is the most adverse prognostic factor and could be included prognostic scores for DLBCL.

O texto completo está disponível em PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas